Tag:
Hanwha Chemical
Latest Headlines
Latest Headlines
Amgen's new Enbrel patent could delay biosims for 17 years
Would-be Enbrel copycats, get out your handkerchiefs. Amgen ( $AMGN ) says it has a new patent protecting the blockbuster anti-inflammatory drug, which could protect it from generic rivals for another
Multinationals eager to jump into the multibillion-dollar biosimilar business
There's a new breed of corporate player jumping into the biotech business. Reuters takes a close look at an unlikely lineup of multinational companies like Samsung , Hanwha Chemical and Fujifilm which
Merck strikes $720M deal with Hanwha for generic Enbrel
Merck has its eye on gaining a piece of the multi-billion dollar market for etanercept ( Enbrel ). The pharma giant has landed a deal to develop and commercialize a knockoff version of Amgen's
